| GA20260-005mg |
|
1802086-51-6 |
(Nle³⁵)-Amyloid β-Protein (1-42)
|
0 |
C204H313N55O60 |
|
|
|
| GA20259-1mg |
|
1802086-31-2 |
(Nle³⁵)-Amyloid β-Protein (1-40)
|
0 |
C195H297N53O58 |
|
|
|
| GA20259-005mg |
|
1802086-31-2 |
(Nle³⁵)-Amyloid β-Protein (1-40)
|
0 |
C195H297N53O58 |
|
|
|
| GA20258-1mg |
|
91869-58-8 |
(Nle²⁷)-GRF (1-29) amide (human)
|
0 |
C150H248N44O42 |
|
|
|
| GA20258-005mg |
|
91869-58-8 |
(Nle²⁷)-GRF (1-29) amide (human)
|
0 |
C150H248N44O42 |
|
|
|
| GA20257-5mg |
|
110863-33-7 |
(Nle¹⁰)-Neurokinin A (4-10)
|
0 |
C35H56N8O10 |
|
|
|
| GA20257-1mg |
|
110863-33-7 |
(Nle¹⁰)-Neurokinin A (4-10)
|
0 |
C35H56N8O10 |
|
|
|
| GA20256-5mg |
|
158563-45-2 |
(Met⁵,Pro⁶,D-Phe⁷,D-Trp⁹,Phe¹⁰)-α-MSH (5-13)
|
0 |
C61H87N15O9S |
|
|
|
| GA20256-1mg |
|
158563-45-2 |
(Met⁵,Pro⁶,D-Phe⁷,D-Trp⁹,Phe¹⁰)-α-MSH (5-13)
|
0 |
C61H87N15O9S |
|
|
|
| GA20255-5mg |
|
181477-43-0 |
(Met¹⁸⁶)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
|
0 |
C47H74N10O14S |
|
|
|
| GA20255-1mg |
|
181477-43-0 |
(Met¹⁸⁶)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
|
0 |
C47H74N10O14S |
|
|
|
| GA20254-1mg |
|
1802086-69-6 |
(Met(O₂)³⁵)-Amyloid β-Protein (1-42)
|
0 |
C203H311N55O62S |
|
|
|
| GA20254-005mg |
|
1802086-69-6 |
(Met(O₂)³⁵)-Amyloid β-Protein (1-42)
|
0 |
C203H311N55O62S |
|
|
|
| GA20253-5mg |
|
292147-12-7 |
(Met(O)³⁵)-Amyloid β-Protein (25-35)
|
0 |
C45H81N13O15S |
|
|
|
| GA20253-1mg |
|
292147-12-7 |
(Met(O)³⁵)-Amyloid β-Protein (25-35)
|
0 |
C45H81N13O15S |
|
|
|
| GA20252-1mg |
|
1802086-68-5 |
(Met(O)³⁵)-Amyloid β-Protein (1-42)
|
0 |
C203H311N55O61S |
|
|
|
| GA20252-005mg |
|
1802086-68-5 |
(Met(O)³⁵)-Amyloid β-Protein (1-42)
|
0 |
C203H311N55O61S |
|
|
|
| GA20251-1mg |
|
178302-50-6 |
(Met(O)³⁵)-Amyloid β-Protein (1-40)
|
0 |
C194H295N53O59S |
|
|
|
| GA20251-005mg |
|
178302-50-6 |
(Met(O)³⁵)-Amyloid β-Protein (1-40)
|
0 |
C194H295N53O59S |
|
|
|
| GA20250-1mg |
|
75217-63-9 |
(Met(O)²⁷)-Glucagon (1-29) (human, rat, porcine)
|
0 |
C153H225N43O50S |
|
|
|
